Literature DB >> 2858214

Beta 1-selective and non-selective beta-adrenoceptor blockade, anaerobic threshold and respiratory gas exchange during exercise.

A A McLeod, K D Knopes, D G Shand, R S Williams.   

Abstract

The effect of oral doses of the beta 1-selective adrenoceptor antagonist atenolol (50 mg), the non-selective antagonist propranolol (40 mg) and placebo was investigated during exercise in a crossover comparison in six healthy but untrained subjects. Descriptors of ventilation, respiratory gas exchange, and arterialized blood lactate and glucose were obtained during steady state bicycle ergometric exercise at 20% and 60% of the subjects' previously determined maximal oxygen uptake (VO2 max). At these work intensities, the previously reported increase of respiratory exchange ratio (RER) during non-selective beta-adrenoceptor blockade was found to be trivial (placebo = 0.96 +/- 0.03 s.e. mean; propranolol = 0.97 +/- 0.01; atenolol = 0.97 +/- 0.04; 60% VO2 max, 10 min exercise) and only present during the early minutes of effort. Oxygen uptake and carbon dioxide production did not differ between treatments. Both drugs produced highly significant falls in peak expiratory flow (PEF) rates and tidal volume (VT) which were compensated by an increase in respiratory rate. PEF, 60% VO2 max: placebo = 3.8 +/- 0.3 l/s; propranolol 3.6 +/- 0.3 l/s (P less than 0.03); atenolol 3.1 +/- 0.3 l/s (P less than 0.01). VT, 60% VO2 max: placebo 2.0 +/- 0.1 l; propranolol 1.8 +/- 0.21 (P less than 0.05); atenolol 1.7 +/- 0.1 1 (P less than 0.01). Arterialized lactate was significantly elevated during work at 20% and 60% VO2 max, but rose progressively at the 60% VO2 max load. Ventilation, oxygen uptake and ventilatory equivalent for carbon dioxide also rose progressively at this workload. Ventilatory equivalent for oxygen showed no significant rise.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2858214      PMCID: PMC1463791          DOI: 10.1111/j.1365-2125.1985.tb02607.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  30 in total

1.  Fuel homeostasis in exercise.

Authors:  P Felig; J Wahren
Journal:  N Engl J Med       Date:  1975-11-20       Impact factor: 91.245

2.  The action of beta-adrenergic blocking and stimulating agents on insulin secretion. Characterization of the type of beta receptor.

Authors:  A Loubatières; M M Mariani; G Sorel; L Savi
Journal:  Diabetologia       Date:  1971-06       Impact factor: 10.122

3.  Selective metabolic and cardiovascular beta receptor antagonism in the rat.

Authors:  H C Stanton
Journal:  Arch Int Pharmacodyn Ther       Date:  1972-04

4.  Anaerobic threshold and respiratory gas exchange during exercise.

Authors:  K Wasserman; B J Whipp; S N Koyl; W L Beaver
Journal:  J Appl Physiol       Date:  1973-08       Impact factor: 3.531

5.  Effects of atropine and propranolol on the oxygen transport system during exercise in man.

Authors:  B Ekblom; A N Goldbarg; A Kilbom; P O Astrand
Journal:  Scand J Clin Lab Invest       Date:  1972-09       Impact factor: 1.713

6.  Effects of beta-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man.

Authors:  S Epstein; B F Robinson; R L Kahler; E Braunwald
Journal:  J Clin Invest       Date:  1965-11       Impact factor: 14.808

7.  Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris.

Authors:  H Aström; H Vallin
Journal:  Br Heart J       Date:  1974-12

8.  Estimation of arterial PO2, PCO2, pH, and lactate from arterialized venous blood.

Authors:  H V Forster; J A Dempsey; J Thomson; E Vidruk; G A DoPico
Journal:  J Appl Physiol       Date:  1972-01       Impact factor: 3.531

9.  Hemodynamic and metabolic responses to exercise after adrenoceptor blockade in humans.

Authors:  A A McLeod; J E Brown; B B Kitchell; F A Sedor; C Kuhn; D G Shand; R S Williams
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1984-03

10.  New approach to assessment of cardioselectivity of beta-blocking drugs.

Authors:  C R Kumana; G E Marlin; C M Kaye; D M Smith
Journal:  Br Med J       Date:  1974-11-23
View more
  4 in total

Review 1.  Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.

Authors:  A N Wadworth; D Murdoch; R N Brogden
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

2.  Twenty-four hour effects of oxprenolol Oros and atenolol on heart rate, blood pressure, exercise tolerance and perceived exertion.

Authors:  M A van Baak; F T Verstappen; B Oosterhuis
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 3.  Beta-adrenoceptor blockade and exercise. An update.

Authors:  M A Van Baak
Journal:  Sports Med       Date:  1988-04       Impact factor: 11.136

4.  The effects of beta-adrenoceptor blockade on breathing during progressive exercise in normal man.

Authors:  S B Pearson; J F Morrison; F G Simpson
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.